MyoKardia Company Profile (NASDAQ:MYOK)

About MyoKardia

MyoKardia logoMyoKardia, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is engaged in the development of therapies for treating cardiovascular diseases. The Company focuses on developing and discovering therapies for hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). In addition, the Company is evaluating MYK-461 and initiated a Phase I clinical program for the treatment of HCM.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MYOK
  • CUSIP:
Key Metrics:
  • Previous Close: $20.86
  • 50 Day Moving Average: $17.76
  • 200 Day Moving Average: $12.73
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -13.22
  • P/E Growth: 0.00
  • Market Cap: $582.28M
  • Outstanding Shares: 27,020,000
Additional Links:
Companies Related to MyoKardia:

Analyst Ratings

Consensus Ratings for MyoKardia (NASDAQ:MYOK) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $23.50 (9.05% upside)

Analysts' Ratings History for MyoKardia (NASDAQ:MYOK)
Show:
DateFirmActionRatingPrice TargetDetails
8/9/2016WedbushReiterated RatingOutperform$22.00View Rating Details
7/20/2016BMO Capital MarketsInitiated CoverageOutperform$3.00 -> $28.00View Rating Details
7/12/2016Credit Suisse Group AGReiterated RatingBuy$16.00 -> $20.00View Rating Details
5/13/2016Cowen and CompanyReiterated RatingBuyView Rating Details
12/3/2015Wells Fargo & Co.Initiated CoverageOutperformView Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for MyoKardia (NASDAQ:MYOK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2016        
8/9/2016Q216($0.33)($0.37)$3.55 million$3.55 millionViewN/AView Earnings Details
5/12/2016Q1($0.53)($0.32)ViewN/AView Earnings Details
3/18/2016Q4($0.68)($0.48)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MyoKardia (NASDAQ:MYOK)
Current Year EPS Consensus Estimate: $-1.32 EPS
Next Year EPS Consensus Estimate: $-1.63 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.34)($0.34)($0.34)
Q3 20161($0.39)($0.39)($0.39)
Q4 20161($0.22)($0.22)($0.22)
Q1 20171($0.26)($0.26)($0.26)
Q2 20171($0.27)($0.27)($0.27)
Q3 20171($0.22)($0.22)($0.22)
Q4 20171($0.20)($0.20)($0.20)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for MyoKardia (NASDAQ:MYOK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for MyoKardia (NASDAQ:MYOK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/3/2015Anastasios GianakakosCEOBuy1,350$10.00$13,500.00View SEC Filing  
11/3/2015Jonathan C FoxInsiderBuy3,000$10.00$30,000.00View SEC Filing  
11/3/2015Mark L PerryDirectorBuy5,000$10.00$50,000.00View SEC Filing  
11/3/2015SanofiMajor ShareholderBuy900,000$10.00$9,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for MyoKardia (NASDAQ:MYOK)
DateHeadline
finance.yahoo.com logoMyoKardia to Present at the 2016 Wedbush PacGrow Healthcare Conference (NASDAQ:MYOK)
finance.yahoo.com - August 10 at 9:27 AM
cnbc.com logoMyoKardia reports 2Q loss (NASDAQ:MYOK)
www.cnbc.com - August 9 at 9:31 AM
publicnow.com logoMyoKardia Reports Second Quarter 2016 Financial Results and Continued Progress on Clinical Programs (NASDAQ:MYOK)
www.publicnow.com - August 9 at 9:31 AM
finance.yahoo.com logoSHaRe Registry Data Published in PNAS Demonstrate the Power of Combining ... (NASDAQ:MYOK)
finance.yahoo.com - July 14 at 9:57 AM
publicnow.com logoSHaRe Registry Data Published in PNAS Demonstrate the Power of Combining Clinical, Genetic and Structural Data to Gain Insight into Hypertrophic Cardiomyopathy (NASDAQ:MYOK)
www.publicnow.com - July 14 at 8:38 AM
insidermonkey.com logoHere’s What To Look For Ahead Of The Myokardia Inc (MYOK) Phase II (NASDAQ:MYOK)
www.insidermonkey.com - July 12 at 1:09 PM
biz.yahoo.com logoMYOKARDIA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:MYOK)
biz.yahoo.com - July 11 at 4:13 PM
publicnow.com logoMyoKardia Announces Topline Clinical Data Supporting Advancement of MYK-461 to Phase 2 PIONEER-HCM Study in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients (NASDAQ:MYOK)
www.publicnow.com - July 11 at 4:13 PM
capitalcube.com logoMyoKardia, Inc. breached its 50 day moving average in a Bearish Manner : MYOK-US : June 28, 2016 (NASDAQ:MYOK)
www.capitalcube.com - June 28 at 9:16 AM
4-traders.com logoCetera Financial Group :'s Parent Company Completes Board with Addition of Industry Leading Executives (NASDAQ:MYOK)
www.4-traders.com - June 16 at 6:30 PM
News IconCetera Parent Company Completes Board Of Directors (NASDAQ:MYOK)
www.fa-mag.com - June 16 at 6:30 PM
biz.yahoo.com logoMYOKARDIA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:MYOK)
biz.yahoo.com - June 8 at 4:24 PM
publicnow.com logoMyoKardia to Present at 2016 UBS Global Healthcare Conference (NASDAQ:MYOK)
www.publicnow.com - May 16 at 7:42 AM
News IconTherapy for obstructive hypertrophic cardiomyopathy receives orphan drug designation (NASDAQ:MYOK)
www.healio.com - May 12 at 10:32 AM
4-traders.com logoMYOKARDIA INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:MYOK)
www.4-traders.com - May 12 at 10:32 AM
publicnow.com logoMyoKardia Reports First Quarter 2016 Financial Results and Operational Progress (NASDAQ:MYOK)
www.publicnow.com - May 12 at 7:57 AM
sg.finance.yahoo.com logoMyoKardia reports 1Q loss (NASDAQ:MYOK)
sg.finance.yahoo.com - May 12 at 7:43 AM
streetinsider.com logoMyoKardia (MYOK) Announces Receipt of Orphan Drug Designation for MYK-461 for Treatment of Symptomatic oHCM (NASDAQ:MYOK)
www.streetinsider.com - May 3 at 10:25 AM
nasdaq.com logoMyoKardia Gets Orphan Drug Designation For MYK-461 For Treatment Of OHCM (NASDAQ:MYOK)
www.nasdaq.com - May 2 at 11:05 AM
finance.yahoo.com logoMyoKardia Receives Orphan Drug Designation for MYK-461 for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) (NASDAQ:MYOK)
finance.yahoo.com - May 2 at 7:30 AM
News IconPCSK9 Inhibitors for Statin Intolerance, Early Beta Blockade in AMI Debated (NASDAQ:MYOK)
www.medscape.com - April 15 at 10:30 AM
publicnow.com logoMyoKardia Names Mary Cranston to Board of Directors (NASDAQ:MYOK)
www.publicnow.com - April 13 at 7:43 AM
finance.yahoo.com logoMYOKARDIA INC Financials (NASDAQ:MYOK)
finance.yahoo.com - March 24 at 1:04 PM
capitalcube.com logoMyoKardia, Inc. :MYOK-US: Earnings Analysis: 2015 By the Numbers (NASDAQ:MYOK)
www.capitalcube.com - March 22 at 3:00 PM
4-traders.com logoMyoKardia : reports 4Q loss (NASDAQ:MYOK)
www.4-traders.com - March 19 at 9:19 AM
4-traders.com logoMYOKARDIA : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) (NASDAQ:MYOK)
www.4-traders.com - March 18 at 9:17 AM
biz.yahoo.com logoMYOKARDIA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:MYOK)
biz.yahoo.com - March 18 at 8:32 AM
sg.finance.yahoo.com logoMyoKardia reports 4Q loss (NASDAQ:MYOK)
sg.finance.yahoo.com - March 18 at 7:43 AM
finance.yahoo.com logoMyoKardia Reports Fourth Quarter and 2015 Financial Results and Key Milestones (NASDAQ:MYOK)
finance.yahoo.com - March 18 at 7:30 AM
News IconSanofi pledges potential $2.26B for next-gen oral drugs (NASDAQ:MYOK)
www.bioworld.com - March 17 at 9:40 AM
thestreet.com logo5 Breakout Stocks to Buy Off Weakness (NASDAQ:MYOK)
www.thestreet.com - March 11 at 6:10 AM
biz.yahoo.com logoMYOKARDIA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:MYOK)
biz.yahoo.com - March 8 at 6:10 AM
finance.yahoo.com logoMyoKardia Names Sunil Agarwal, M.D., to Board of Directors, New VPs Strengthen Research and Development (NASDAQ:MYOK)
finance.yahoo.com - March 7 at 7:30 AM
News Icon$100 Billion French Pharma Giant Sanofi says they’re on the “Hunt” for Rare Disease Acquisitions: Here’s who they may be Eyeballing (NASDAQ:MYOK)
www.ssuchronicle.com - March 6 at 8:48 AM
finance.yahoo.com logoMyoKardia to Present at Cowen and Company 36th Annual Health Care Conference (NASDAQ:MYOK)
finance.yahoo.com - March 1 at 8:00 AM
News IconPrecision Medicine Prevents Common Cardiovascular Disease in Mice (NASDAQ:MYOK)
www.biosciencetechnology.com - February 29 at 5:54 PM
biz.yahoo.com logoMYOKARDIA INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat (NASDAQ:MYOK)
biz.yahoo.com - February 23 at 11:33 AM
finance.yahoo.com logoMyoKardia Announces Transition of Chief Medical Officer (NASDAQ:MYOK)
finance.yahoo.com - February 23 at 8:00 AM
bizjournals.com logoRedwood City startup snags $45M to take on deadly lung disease (NASDAQ:MYOK)
www.bizjournals.com - February 18 at 5:41 PM
thestreet.com logoIWN's Underlying Holdings Could Mean 27% Gain Potential (NASDAQ:MYOK)
www.thestreet.com - February 11 at 8:21 AM
News IconSudden cardiac death may soon be a thing of past (NASDAQ:MYOK)
timesofindia.indiatimes.com - February 8 at 5:26 PM
News IconPioneering Discovery Could Lead to Preventive Treatment for Sudden Cardiac Death (NASDAQ:MYOK)
www.medindia.net - February 8 at 8:03 AM
News IconStaving off sudden heart death may soon be possible (NASDAQ:MYOK)
zeenews.india.com - February 7 at 7:59 AM
News IconScientists find potential treatment for sudden cardiac death (NASDAQ:MYOK)
www.newkerala.com - February 7 at 7:59 AM
News IconPioneering discovery leads to potential preventive treatment for sudden cardiac death (NASDAQ:MYOK)
www.sciencecodex.com - February 5 at 5:25 PM
biz.yahoo.com logoMYOKARDIA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:MYOK)
biz.yahoo.com - February 5 at 1:24 PM
News IconMyoKardia Science article demonstrates MYK-461 prevents and reverses disease in HCM mice (NASDAQ:MYOK)
www.eurekalert.org - February 4 at 5:27 PM
globenewswire.com logoSupports Therapeutic Hypothesis Linking Reduction in Sarcomere Power Output to Improvements in Structural Pathology of HCM (NASDAQ:MYOK)
globenewswire.com - February 4 at 5:27 PM
nasdaq.com logoMyoKardia Publishes Article in Science Demonstrating That MYK-461 Prevents and Reverses Disease in (NASDAQ:MYOK)
www.nasdaq.com - February 4 at 5:27 PM
finance.yahoo.com logo2:03 pm MyoKardia publishes article in medical journal 'Science' which demonstrates the ability of MYK-461 to prevent and reverse development of disease in multiple genetic mouse models of hypertrophic cardiomyopathy (NASDAQ:MYOK)
finance.yahoo.com - February 4 at 2:03 PM

Social

MyoKardia (NASDAQ:MYOK) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff